Restaurant Stock Ripe for Bullish Trade

The Nasdaq and S&P kept their heads above water, though

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MARKET RECAP     7/09/2019
A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Brings Daily Losing Streak to 3 By Karee Venema Share On The Dow spent the entire session in negative territory, pressured by sharp losses for newly downgraded Post-it maker 3M (MMM), ending lower for a third straight day. Anxiety continued to build ahead of Fed Chair Jerome Powell's appearance in front of the House Financial Services Committee tomorrow, while the minutes from the Fed's June meeting are also due. The S&P was in the red with the Dow most the day, but ultimately closed higher with the Nasdaq thanks to a strong showing from tech stocks. Continue reading for more on today's market, including: This restaurant stock seems ripe for a bullish options trade. A Huawei warning sent this tech stock to its fifth straight loss. AMD saw its price target lifted after this weekend's Ryzen 3000 chip launch. Plus, options traders reacted to Square's upgrade; why BBBY stock could be volatile on Thursday; and the hospitality stock J.P. Morgan is dropping. >> Continue reading...
LATEST HEADLINES
>> Analyst: Drop This Hospitality Stock Now J.P. Morgan Securities downgraded the shares to "underweight" >> Huawei Warning Sparks Accelerated Cohu Put Trading Cohu said U.S. restrictions on Huawei is hurting its customers' business >> 3 Stocks Seeing Analyst Love Today Netflix analysts are cheering season 3 of "Stranger Things" >> Square Bulls Emerge After Analyst Upgrade "The negative catalysts have mostly played out," Raymond James said >> Infosys Options Hot Ahead of Earnings A huge number of options players are buying Infosys puts before this Friday's earnings report ADVERTISEMENT Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MARKET RECAP enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com